Lexagene in the Media
October 1, 2021
Dr. Jack Regan, CEO of LexaGene, shares his work identifying the future biothreats human and veterinary populations may face.

September 16, 2021
GenomeWeb picked up our announcement and reports on LexaGene’s cooperative research agreement with the US Army.

July 22, 2021
In the latest issue of the Pathologist, Dr. Jack Regan discusses the strategic priorities and technologies that could prevent the next global pandemic:

May 10, 2021
Benzinga describes how LexaGene has built MiQLab, a new molecular diagnostics analyzer that can do in-clinic veterinary diagnostic testing at the point-of-care.

February 3, 2021
LexaGene covered in BioWorld on the MiQLab’s ability to detect new variants of pathogens at point-of-care.

January 18, 2021
Read BioSpace’s recent coverage of LexaGene’s plans to submit for FDA Emergency Use Authorization, and how the MiQLab™ system is ideally suited to test for COVID-19 variants at point-of-care.

January 15, 2021
LexaGene was recently covered by Outbreak News Today on the news that LexaGene will begin in-house testing for variants of COVID-19.

December 12, 2020
LexaGene’s new automated testing platform in Medical Technology

November 24, 2020
American Animal Hospital Association (AAHA)’s NEWStat publication reviews LexaGene’s MiQLab system in a recent feature.

July 13, 2020
Trends in COVID-19 Testing: Diagnostics and Serological

May 1, 2020
Here is an excerpt from Science News featuring Dr. Regan’s insights.

March 27, 2020
‘It’s hard to imagine a startup better positioned to respond to the coronavirus pandemic than Beverly, Massachusetts-based LexaGene.’

March 26, 2020
Dr. Jack Regan, CEO and Founder of LexaGene quoted in Boston Herald article on the potential resurgence of COVID-19 in the fall.

March 20, 2020
“LexaGene responds to demand for better diagnostics for COVID-19.”

March 16, 2020
Testing for the coronavirus could be done in an hour without lab-trained technicians using a device the size of a Keurig coffee machine.

February 25, 2020
The LX Analyzer will be a game-changing way to run these tests quickly and cost-effectively to diagnose disease and to detect novel pathogens.

February 6, 2020
LexaGene CEO Dr. Jack Regan mentioned in Forbes article on the potential infection rate of COVID-19 and worldwide impact.

February 4, 2020
CEO Dr. Jack Regan on the challenges of self-quarantine measures during the 2019 coronavirus outbreak.

February 4, 2020
Read local coverage of LexaGene’s development of a genetic analyzer to detect viruses like coronavirus:

February 3, 2020
LexaGene featured on ABC affiliate WCVB News Boston on how the company plans to help with better testing for the rapid detection of COVID-19.

December 10, 2019
This Forbes full-length feature on LexaGene and our technology describes how LexaGene could be the next big medical breakthrough.

December 5, 2019
LexaGene is tackling the challenge of improving food safety and reducing recalls.

December 5, 2019
Dr. Regan discusses the challenge of antibiotic resistance threats and how LexaGene’s analyzer can help improve antibiotic stewardship.

October 8, 2019
LexaGene is bringing better detection to the cannabis testing market.

October 4, 2019
Boston Business Journal featured LexaGene in a story about how the company is trying to tackle possible under-reporting of EEE virus.

August 7, 2019
The CDC and FDA AR Isolate Bank will provide information to LexaGene which will support the company’s diagnostics development and help address the serious issue of antibiotic resistance.

February 21, 2019
LexaGene is setting the bar high for food safety testing.

December 19, 2018
LexaGene has been voted among the “10 Most Promising Food and Beverages Solution Providers 2018” by CIOReview.

September 26, 2018
How can food producers prevent recalls and consumers from falling ill?

May 3, 2018
Dr. Jack Regan discusses the importance of open-access diagnostics in pandemic prevention.

April 5, 2018
We spoke about LexaGene’s mission to make it as simple and easy as possible for people to detect pathogens.

March 7, 2018
Much needed innovation in food safety testing is within sight: Improving Molecular testing to help Minimize Risk of Food Recalls.

February 20, 2018
CEO Jack Regan discusses LexaGene’s approach to food safety and plans over the next 6-10 months in Food Quality News.

January 22, 2018
Learn how LexaGene’s rapid-testing technology can impact the food processing market and enhance food safety.

November 6, 2017
LexaGene founder and CEO Jack Regan was featured on leading business site Inc.com, where he shares his wisdom about daily habits for success.